It is well established that families carrying a germline BRCA1 mutation have increased incidence of basal-like/triple-negative breast cancers, while germline BRCA2 mutations predispose to cancers of the lumB subtype [22-24]. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.